Clinical Trial Update: Antioxidant Supplementation in Trauma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating antioxidant supplementation in polytrauma patients has been terminated. The sponsor is Boston Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polytrauma

Snippet

Sponsor: Boston Medical Center | Conditions: Multiple Trauma | Phase 3 | Status: TERMINATED